For the 30 percent of clinically depressed people who don’t respond to medication, the U.S. Food and Drug Administration recently approved a new, noninvasive treatment option. With NeuroStar TMS, a wand held over the head delivers highly focused magnetic pulses to a part of the brain that’s been linked to depression. A typical course of treatment would involve 40-minute sessions at a psychiatrist’s office five times a week for four to six weeks. In two clinical trials, roughly half of patients said that their symptoms were reduced by at least 50 percent.
Courtesy of Neuronetics
Product: NeuroStar TMS Therapy system
Cost: Approximately $6,000 for a course of 20 to 30 sessions, depending on the provider
Other products in this section:
Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.Subscribe today
Subscribe to Continue Reading
Uh oh–you've read all of your free articles for this month.
Still No Science Advisor at the White House
Science issues stack up as President Trump overlooks an appointment.
How a Smart Watch Can Predict Your Happiness Levels
Happiness is an elusive state of mind that many people aim to maximize. Now researchers have found a way to predict happiness levels using smart watch data.
Gene Therapy Could Help People Overcome Meth Addiction
There are currently no medications available to treat methamphetamine abuse disorders